These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 28389561)

  • 1. Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis.
    Ghatak S; Hascall VC; Markwald RR; Feghali-Bostwick C; Artlett CM; Gooz M; Bogatkevich GS; Atanelishvili I; Silver RM; Wood J; Thannickal VJ; Misra S
    J Biol Chem; 2017 Jun; 292(25):10490-10519. PubMed ID: 28389561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2.
    Fierro-Fernández M; Busnadiego Ó; Sandoval P; Espinosa-Díez C; Blanco-Ruiz E; Rodríguez M; Pian H; Ramos R; López-Cabrera M; García-Bermejo ML; Lamas S
    EMBO Rep; 2015 Oct; 16(10):1358-77. PubMed ID: 26315535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor β1 (TGFβ1) regulates CD44V6 expression and activity through extracellular signal-regulated kinase (ERK)-induced EGR1 in pulmonary fibrogenic fibroblasts.
    Ghatak S; Markwald RR; Hascall VC; Dowling W; Lottes RG; Baatz JE; Beeson G; Beeson CC; Perrella MA; Thannickal VJ; Misra S
    J Biol Chem; 2017 Jun; 292(25):10465-10489. PubMed ID: 28389562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhoA/Rho kinase mediates TGF-β1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species.
    Manickam N; Patel M; Griendling KK; Gorin Y; Barnes JL
    Am J Physiol Renal Physiol; 2014 Jul; 307(2):F159-71. PubMed ID: 24872317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts.
    Amara N; Goven D; Prost F; Muloway R; Crestani B; Boczkowski J
    Thorax; 2010 Aug; 65(8):733-8. PubMed ID: 20685750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury.
    Hecker L; Vittal R; Jones T; Jagirdar R; Luckhardt TR; Horowitz JC; Pennathur S; Martinez FJ; Thannickal VJ
    Nat Med; 2009 Sep; 15(9):1077-81. PubMed ID: 19701206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin attenuates lung fibrosis development via NOX4 suppression.
    Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
    Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NADPH oxidase 4 is dispensable for skin myofibroblast differentiation and wound healing.
    Siedlar AM; Seredenina T; Faivre A; Cambet Y; Stasia MJ; André-Lévigne D; Bochaton-Piallat ML; Pittet-Cuénod B; de Seigneux S; Krause KH; Modarressi A; Jaquet V
    Redox Biol; 2023 Apr; 60():102609. PubMed ID: 36708644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
    Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4.
    Tsubouchi K; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Sato N; Yoshida M; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Nakanishi Y; Kuwano K
    Autophagy; 2017 Aug; 13(8):1420-1434. PubMed ID: 28613983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β
    Guo W; Saito S; Sanchez CG; Zhuang Y; Gongora Rosero RE; Shan B; Luo F; Lasky JA
    Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L936-L944. PubMed ID: 28336812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromodomain and Extraterminal (BET) Protein Inhibition Restores Redox Balance and Inhibits Myofibroblast Activation.
    Stock CJW; Michaeloudes C; Leoni P; Durham AL; Mumby S; Wells AU; Chung KF; Adcock IM; Renzoni EA; Lindahl GE
    Biomed Res Int; 2019; 2019():1484736. PubMed ID: 31119153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma.
    Sampson N; Koziel R; Zenzmaier C; Bubendorf L; Plas E; Jansen-Dürr P; Berger P
    Mol Endocrinol; 2011 Mar; 25(3):503-15. PubMed ID: 21273445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming Growth Factor β1-induced Apoptosis in Podocytes via the Extracellular Signal-regulated Kinase-Mammalian Target of Rapamycin Complex 1-NADPH Oxidase 4 Axis.
    Das R; Xu S; Nguyen TT; Quan X; Choi SK; Kim SJ; Lee EY; Cha SK; Park KS
    J Biol Chem; 2015 Dec; 290(52):30830-42. PubMed ID: 26565025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The matricellular protein CCN1 enhances TGF-β1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury.
    Kurundkar AR; Kurundkar D; Rangarajan S; Locy ML; Zhou Y; Liu RM; Zmijewski J; Thannickal VJ
    FASEB J; 2016 Jun; 30(6):2135-50. PubMed ID: 26884454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts.
    Bondi CD; Manickam N; Lee DY; Block K; Gorin Y; Abboud HE; Barnes JL
    J Am Soc Nephrol; 2010 Jan; 21(1):93-102. PubMed ID: 19926889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
    Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
    Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic disease.
    Sampson N; Berger P; Zenzmaier C
    Biomed Res Int; 2014; 2014():131737. PubMed ID: 24701562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulation of NADPH oxidase 4 by hydrogen peroxide-inducible clone 5 (Hic-5) protein.
    Desai LP; Zhou Y; Estrada AV; Ding Q; Cheng G; Collawn JF; Thannickal VJ
    J Biol Chem; 2014 Jun; 289(26):18270-8. PubMed ID: 24831009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A key role for NOX4 in epithelial cell death during development of lung fibrosis.
    Carnesecchi S; Deffert C; Donati Y; Basset O; Hinz B; Preynat-Seauve O; Guichard C; Arbiser JL; Banfi B; Pache JC; Barazzone-Argiroffo C; Krause KH
    Antioxid Redox Signal; 2011 Aug; 15(3):607-19. PubMed ID: 21391892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.